EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections

Abeer Alfadhli, Shankave Sritharan, Diya Rangrej, Jeffrey Ian Weitz, Zeinab Hosseinidoust iD, Tohid F Didar iD

ACS Infectious Diseases · 09.10.2026 · 12 (10) · 3309-3321

DOI: 10.1021/acsinfecdis.6c00563 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, online erschienen am 26.09.2026. Verfasst von Abeer Alfadhli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, McMaster University, Hamilton, OntarioL8S 4L8, Canada. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Phage Therapy, Bacteriophages. Die Arbeit nennt 135 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular implant infections significantly impact morbidity and mortality. Bacteriophage therapy has emerged as a potential strategy for device-related infection, particularly in biofilm-associated settings where conventional antimicrobial therapy is limited, often necessitating device removal. This review outlines phage treatment principles, including biofilm invasion, phage-antibiotic interaction, phage resistance, and infection protection mechanisms. We explore innovative approaches for using bacteriophages to treat infections around prosthetic vascular grafts, heart valves, left ventricular assist devices, and cardiac implantable electronic devices. Key issues in using bacteriophages for cardiovascular device infections include phage selection, resistance detection, phage production, regulatory aspects, and experimental models considering infection and device flow dynamics. Although clinical trials on phage therapy effectiveness are unavailable, its promise is significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsPhage TherapyBacteriophagesHumansBiofilmsAnimalsAnti-Bacterial Agents

Stichwörter der Autor:innen

antibiotic resistancebacteriophage therapybiofilmcardiovascular device infectionvascular graft infection

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Surgery, McMaster University, Hamilton, OntarioL8S 4L8, Canada.
  • School of Biomedical Engineering, McMaster University, Hamilton, OntarioL8S 4L8, Canada.
  • Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, OntarioL8S 4L8, Canada.
  • Department of Health Sciences, McMaster University, Hamilton, OntarioL8S 4L8, Canada.
  • Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, OntarioL8S 4L8, Canada.
  • Department of Chemical Engineering, McMaster University, Hamilton, OntarioL8S 4L8, Canada.

ORCID-Profile: Zeinab Hosseinidoust, Tohid F Didar

Zitieren

APA

Alfadhli, A., Sritharan, S., Rangrej, D., Weitz, J. I., Hosseinidoust, Z., & Didar, T. F. (2026). Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections. ACS Infectious Diseases, 12(10), 3309-3321. https://doi.org/10.1021/acsinfecdis.6c00563

Vancouver

Alfadhli A, Sritharan S, Rangrej D, Weitz JI, Hosseinidoust Z, Didar TF. Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections. ACS Infectious Diseases. 2026;12(10):3309-3321. doi:10.1021/acsinfecdis.6c00563

BibTeX
@article{Alfadhli2026,
  author = {Alfadhli, Abeer and Sritharan, Shankave and Rangrej, Diya and Weitz, Jeffrey Ian and Hosseinidoust, Zeinab and Didar, Tohid F},
  title = {Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {10},
  pages = {3309--3321},
  doi = {10.1021/acsinfecdis.6c00563}
}
Kostenlos starten →